Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitafloxacin Fumarate Injection in Acute Pyelonephritis/Complicated UTI (Phase II)
CTR20211834Phase 2Completed
- Sponsor
- Nanjing Yoko Pharmaceutical
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitafloxacin in acute pyelonephritis, complicated urinary tract infection (cUTI), sponsored by Nanjing Yoko Pharmaceutical. Started Jul 2021; status: completed.
02
Drugs
sitafloxacin
03
Conditions
acute pyelonephritiscomplicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on CTR20211834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211834.